Gosset Molecular Classification
Receptor, Ligand-gated ion channel subunit (part of GABAA receptor complex), Allosteric binding site
Other Names
BZ receptor, Benzodiazepine receptor, BDZ receptor, GABAA receptor benzodiazepine binding site
Disease Roles
Benzodiazepine-type Receptor Overview
The benzodiazepine-type receptor refers to specific allosteric binding sites located on the GABAA receptor complex in the central nervous system. These sites are the molecular targets for benzodiazepine drugs, which are widely used for their anxiolytic, sedative, muscle relaxant, and anticonvulsant properties. Benzodiazepines act as positive allosteric modulators, enhancing the effect of the endogenous ligand GABA by increasing the affinity of the GABA binding site. This leads to increased chloride ion influx, hyperpolarization of neurons, and increased inhibitory neurotransmission.
Mechanism of Action
Positive allosteric modulation of the GABAA receptor
Biological Functions
Modulation of GABAergic neurotransmission
Regulation of chloride ion channel activity
Inhibition of neuronal excitability
Disease Associations
Anxiety disorders
Insomnia
Seizures
Muscle spasticity
Alcohol withdrawal
Safety Considerations
- Tolerance
- Dependence
- Withdrawal syndrome
- Cognitive impairment
- Respiratory depression (especially in combination with other CNS depressants)
- Falls (especially in elderly patients)
Interacting Drugs
Benzodiazepines (e.g., diazepam)